Most are sold without a prescription and contain herbal or supplement ingredients rather than the regulated GLP-1 medication found in prescription injections, which is why the category causes so much confusion
If sulfur burps remain severe and intolerable despite all interventions after 8 to 12 weeks, discuss alternative medications or dose adjustments with your prescriber rather than stopping treatment entirely
Retatrutide is an investigational once-weekly injectable triple receptor agonist that simultaneously activates GLP-1, GIP, and glucagon receptors to reduce appetite, increase energy expenditure, and improve metabolic function
Brain receptors promote feelings of satiety and reduce food cravings, helping to manage caloric intake
It alerts healthcare professionals (HCPs) to the potential risk of pulmonary aspiration in people using GLP-1 or dual GIP/GLP-1 receptor agonists (RAs) who undergo surgery or procedures with general anaesthesia or deep sedation